Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuichirou, Doki"'
Autor:
Ryota, Mukai, Hidetoshi, Eguchi, Hiroshi, Wada, Kouichi, Kawamoto, Shogo, Kobayashi, Shigeru, Marubashi, Masahiro, Tanemura, Koji, Umeshita, Yuichirou, Doki, Masaki, Mori, Hiroaki, Nagano
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(12)
A 73-year-old man with advanced multiple hepatocellular carcinoma(HCC) in both lobes(S2, S3, S4, S8, and S1) was admitted to our hospital. Abdominal computed tomography revealed neither vascular invasion nor distant metastasis. Because 3 attempts of
Autor:
Naotsugu, Haraguchi, Hideshi, ishii, Daisuke, Sakai, Taroh, Satoh, Yuichirou, Doki, Masaki, Mori
Publikováno v:
Nihon Geka Gakkai zasshi. 113(2)
Functional heterogeneity occurs in tumor withs a hierarchy in which tumor growth is driven by a small subset of cancer stem cells (CSCs). Like normal tissue stem cells, which are capable of self-renewal and multi-differentiation, CSCs have the abilit
Autor:
Sakae, Maeda, Hidetoshi, Eguchi, Hiroshi, Wada, Shogo, Kobayashi, Shigeru, Marubashi, Masahiro, Tanemura, Koji, Umeshita, Yuichirou, Doki, Masaki, Mori, Hiroaki, Nagano
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(12)
Treatments for hepatocellular carcinoma (HCC) include surgical resection, transcatheter arteral chemoembolization (TACE), percutaneous local therapy and systemic chemotherapy. However, it is difficult to perform a curative treatment for patients with
Autor:
Shoji, Nakamori, Wakio, Endo, Hiroki, Ozato, Takashi, Shibata, Yutaka, Takeda, Ken, Tohno, Yasunori, Hasuike, Seizo, Masutani, Takashi, Morimoto, Yuichirou, Doki, Masaki, Mori, Morito, Monden
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(5)
Our objective was to evaluate the efficacy and toxicity of the pre-administration of UFT (uracil/tegafur: prodrug of 5-FU) and GEM combination therapy for unresectable/recurrent pancreatic cancer in the outpatient setting. UFT (250mg/m(2)/day) was or
Autor:
Tsukasa, Tanida, Masahiro, Tanemura, Shogo, Kobayashi, Hiroshi, Wada, Shigeru, Marubashi, Hidetoshi, Eguchi, Yutaka, Takeda, Hiroshi, Umeshita, Masaki, Mori, Yuichirou, Doki, Hiroaki, Nagano
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(12)
To cure intrahepatic cholangiocarcinoma (ICC), only a surgical resection is the potential treatment at present. However, recurrence tumors in residual liver and/or distant organs even after curative surgery are commonly experienced in clinical course
Autor:
Yoshiyuki, Fujiwara, Jyunya, Fujita, Kazuomi, Kan, Kousei, Tsukahara, Shuji, Takiguchi, Hiroshi, Miyata, Takushi, Yasuda, Yuichirou, Doki, Morito, Monden
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 33(1)
The safety of chemotherapy combining TS-1 and weekly paclitaxel for the treatment of unresectable and recurrent gastric cancer was evaluated in this study. Paclitaxel was administered by intravenous drip infusion at a starting dose (level 1) of 50 mg